content top

Intravitreal Ranibizumab Monotherapy in Naive Eyes with Myopic Choroidal Neovascularisation

ABSTRACT Purpose: To report the results anatomical and visual outcomes of intravitreal ranibizumab (IVR) monotherapy in naive eyes with myopic choroidal neovascularization (mCNV). Material & Methods: Retrospective analysis of naive CNV secondary to myopia that underwent antivascular endothelial growth factor monotherapy was performed. Collected data included demographic details, clinical examination details including visual acuity at...

Read More

Refractory Subfoveal Subretinal Fluid in Neovascular ARMD: Is There a Protective Effect on Good Visual Acuity?

Purpose: To investigate the functional outcome of eyes with neovascular age-related macular degeneration (nAMD) treated with ranibizumab which retain good visual acuity despite chronic, persistent subretinal fluid (SRF). Methods: This retrospective, interventional case series included 12 eyes of 11 patients with nAMD which have (mean age, 70.2 years; range, 58 to 78 years) persistent SRF despite anti-VEGF therapy, and good long-term visual...

Read More
content top